Indivior Pharmaceuticals (INDV) Prepaid Assets (2021 - 2026)
Indivior Pharmaceuticals' (INDV) quarterly Prepaid Assets came in at $40.0 million in Q1 2026, up 100.0% year-on-year from $20.0 million in Q1 2025, and up 17.65% quarter-over-quarter from $34.0 million in Q4 2025.
Indivior Pharmaceuticals (INDV) Prepaid Assets (2021 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Prepaid Assets history runs 6 years deep, the most recent figure standing at $40.0 million for Q1 2026.
- On a quarterly basis, Prepaid Assets rose 100.0% year-over-year to $40.0 million in Q1 2026; TTM through Mar 2026 was $40.0 million, a 100.0% increase from a year earlier, with the FY2025 full-year figure at $34.0 million, up 61.9% from the prior year.
- Prepaid Assets grew to $40.0 million in Q1 2026 per INDV's latest filing, from $34.0 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $52.0 million in Q4 2023 and bottomed at $20.0 million in Q1 2025.
- The 5-year median for Prepaid Assets is $29.0 million (2025), against an average of $31.5 million.
- Across the five-year window, Prepaid Assets slumped 59.62% in 2024 and jumped 100.0% in 2026, its largest moves.
- Year by year, Prepaid Assets stood at $27.0 million in 2022, then soared by 92.59% to $52.0 million in 2023, then slumped by 59.62% to $21.0 million in 2024, then surged by 61.9% to $34.0 million in 2025, then rose by 17.65% to $40.0 million in 2026.
- Per Business Quant, the three latest INDV Prepaid Assets figures stand at $40.0 million (Q1 2026), $34.0 million (Q4 2025), and $30.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Indivior Pharmaceuticals | 1.00 Bn | 829.65 Mn | 277.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.00 Mn |
| Dec 31, 2025 | 34.00 Mn |
| Sep 30, 2025 | 30.00 Mn |
| Jun 30, 2025 | 28.00 Mn |
| Mar 31, 2025 | 20.00 Mn |
| Dec 31, 2024 | 21.00 Mn |
| Dec 31, 2023 | 52.00 Mn |
| Dec 31, 2022 | 27.00 Mn |
| Dec 31, 2021 | 32.00 Mn |